131 related articles for article (PubMed ID: 8105489)
1. Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats.
Meyer ME
Pharmacol Biochem Behav; 1993 Aug; 45(4):843-7. PubMed ID: 8105489
[TBL] [Abstract][Full Text] [Related]
2. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats.
Meyer ME; Van Hartesveldt C; Potter TJ
Synapse; 1993 Apr; 13(4):310-4. PubMed ID: 8097596
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats.
Meyer ME; Shults JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):269-74. PubMed ID: 7903456
[TBL] [Abstract][Full Text] [Related]
4. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
Dreher JK; Jackson DM
Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
[TBL] [Abstract][Full Text] [Related]
5. Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats.
Meyer ME; Cottrell GA; Van Hartesveldt C; Potter TJ
Pharmacol Biochem Behav; 1993 Feb; 44(2):429-32. PubMed ID: 8446676
[TBL] [Abstract][Full Text] [Related]
6. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
7. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.
Kaddis FG; Wallace LJ; Uretsky NJ
Pharmacol Biochem Behav; 1993 Nov; 46(3):703-8. PubMed ID: 7506423
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D1 receptors in the sub-commissural part of the globus pallidus and their role in oro-facial dyskinesia in cats.
Spooren WP; Piosik PA; Cools AR
Eur J Pharmacol; 1991 Nov; 204(2):217-22. PubMed ID: 1839622
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
Nagashima M; Yamada K; Kimura H; Matsumoto S; Furukawa T
Pharmacol Biochem Behav; 1992 Dec; 43(4):993-7. PubMed ID: 1361996
[TBL] [Abstract][Full Text] [Related]
10. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
11. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
Shieh GJ; Walters DE
Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm.
Ukai M; Mori E; Kameyama T
Pharmacol Biochem Behav; 1993 Apr; 44(4):907-11. PubMed ID: 8097045
[TBL] [Abstract][Full Text] [Related]
13. The role of the nucleus accumbens in learned approach behavior diminishes with training.
Dobrovitsky V; West MO; Horvitz JC
Eur J Neurosci; 2019 Nov; 50(9):3403-3415. PubMed ID: 31340074
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
[TBL] [Abstract][Full Text] [Related]
15. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations.
Moody CA; Robinson SR; Spear LP; Smotherman WP
Pharmacol Biochem Behav; 1993 Apr; 44(4):843-50. PubMed ID: 8097042
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
17. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
Messier C; Mrabet O; Destrade C
Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
[TBL] [Abstract][Full Text] [Related]
20. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
